Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Ronald Kronemann who wrote (807)	6/1/1999 10:16:00 PM
From: LLLefty	Read Replies (1) \| Respond to of 1386

Just a footnote to a discussion on medical marijuana I heard on PBS this morning. While I caught only bits and pieces, a Dr. "Greenspoon" (?), a Harvard associate professor of psychiatry, noted that there was only one serious marijuana study underway of an analog called HU-211 by an Israeli company which he did not name. He said this in conjunction with a comment that the large drug companies won't put any money into research because marijuana itself is not patentable.